Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1970 1
1972 1
1973 1
1976 2
1977 3
1978 5
1979 4
1980 5
1981 9
1982 13
1983 12
1984 27
1985 32
1986 40
1987 49
1988 39
1989 38
1990 28
1991 37
1992 31
1993 33
1994 29
1995 27
1996 29
1997 31
1998 26
1999 27
2000 23
2001 24
2002 28
2003 25
2004 17
2005 24
2006 20
2007 22
2008 19
2009 13
2010 20
2011 22
2012 16
2013 15
2014 23
2015 15
2016 17
2017 26
2018 40
2019 45
2020 48
2021 60
2022 77
2023 60
2024 69
2025 63
2026 52

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,393 results

Results by year

Filters applied: . Clear all
Page 1
Nalbuphine.
Schmidt WK, Tam SW, Shotzberger GS, Smith DH Jr, Clark R, Vernier VG. Schmidt WK, et al. Drug Alcohol Depend. 1985 Feb;14(3-4):339-62. doi: 10.1016/0376-8716(85)90066-3. Drug Alcohol Depend. 1985. PMID: 2986929 Review.
Nalbuphine is a potent analgesic with a low side effect and dependence profile in animals and man. ...Rather, due to nalbuphine's strong antagonist activity, analgesic-range doses of nalbuphine severely exacerbate the withdrawal syndrome in partly-withdrawn m …
Nalbuphine is a potent analgesic with a low side effect and dependence profile in animals and man. ...Rather, due to nalbuphine …
Nalbuphine #381.
Mathai F, Portugal F, Mehta Z, Davis M. Mathai F, et al. J Palliat Med. 2019 Nov;22(11):1471-1472. doi: 10.1089/jpm.2019.0482. J Palliat Med. 2019. PMID: 31661394 No abstract available.
Intravenous nalbuphine.
Welch GW, Feldman HS. Welch GW, et al. Anesth Analg. 1981 Mar;60(3):168. doi: 10.1213/00000539-198103000-00009. Anesth Analg. 1981. PMID: 7193992 No abstract available.
Does nalbuphine have a niche in managing pain?
Davis MP, Fernandez C, Regel S, McPherson ML. Davis MP, et al. J Opioid Manag. 2018 Mar/Apr;14(2):143-151. doi: 10.5055/jom.2018.0441. J Opioid Manag. 2018. PMID: 29733100 Review.
Nalbuphine pharmacokinetics are moderately altered in renal failure. Several studies have found that nalbuphine reduces uremic pruritus. ...Nalbuphine, despite being a receptor antagonist produces a drug-liking effect and can be abused. ...
Nalbuphine pharmacokinetics are moderately altered in renal failure. Several studies have found that nalbuphine reduces uremic …
Nalbuphine and pruritus.
Ramsay MA, Flanders D. Ramsay MA, et al. Anaesthesia. 1997 Oct;52(10):1023. Anaesthesia. 1997. PMID: 9370866 Free article. No abstract available.
Pre-hospital nalbuphine analgesia.
Jones AG. Jones AG. J Accid Emerg Med. 1999 Nov;16(6):462. doi: 10.1136/emj.16.6.462. J Accid Emerg Med. 1999. PMID: 10572835 Free PMC article. No abstract available.
Enhancing prehospital analgesia - advantages and further indications of nalbuphin.
Jansen G, Deslandes M, Deicke M, Grannemann JJ, Hoyer A, Kalmbach M, Kobiella A, Plappert T, Strickmann B, Hinkelbein J. Jansen G, et al. Scand J Trauma Resusc Emerg Med. 2024 Jun 12;32(1):56. doi: 10.1186/s13049-024-01227-9. Scand J Trauma Resusc Emerg Med. 2024. PMID: 38867316 Free PMC article. No abstract available.
[Pharmacology of nalbuphine].
Arnould JF, Pinaud M. Arnould JF, et al. Ann Fr Anesth Reanim. 1992;11(2):221-8. doi: 10.1016/S0750-7658(05)80018-8. Ann Fr Anesth Reanim. 1992. PMID: 1503299 Review. French. No abstract available.
The use of nalbuphine in paediatric anaesthesia.
Kubica-Cielińska A, Zielińska M. Kubica-Cielińska A, et al. Anaesthesiol Intensive Ther. 2015;47(3):252-6. doi: 10.5603/AIT.2015.0036. Anaesthesiol Intensive Ther. 2015. PMID: 26165241 Free article. Review.
Nalbuphine is an agonist-antagonist opioid. It causes analgesic and sedative effect and because of ceiling effect it does not cause a respiratory depression. ...After sevoflurane anaesthesia of small children, it reduces the incidences of emergence agitation. Nalbuphine …
Nalbuphine is an agonist-antagonist opioid. It causes analgesic and sedative effect and because of ceiling effect it does not cause a …
Evaluation of nalbuphine hydrochloride.
Miller RR. Miller RR. Am J Hosp Pharm. 1980 Jul;37(7):942-9. Am J Hosp Pharm. 1980. PMID: 6994499 Review.
Acute, subacute, and chronic toxicity studies in animals revealed no unusual adverse effects. The abuse potential of nalbuphine in man is probably similar to pentazocine. Respiratory depression produced by usual therapeutic doses of nalbuphine is equivalent to that …
Acute, subacute, and chronic toxicity studies in animals revealed no unusual adverse effects. The abuse potential of nalbuphine in ma …
1,393 results